Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

Towards a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multi-center study (CTCTrap).

Andree KC, Mentink A, Zeune LL, Terstappen LWMM, Stoecklein NH, Neves RP, Driemel C, Lampignano R, Yang L, Neubauer H, Fehm T, Fischer JC, Rossi E, Manicone M, Basso U, Marson P, Zamarchi R, Loriot Y, Lapierre V, Faugeroux V, Oulhen M, Farace F, Fowler G, Sousa Fontes M, Ebbs B, Lambros M, Crespo M, Flohr P, de Bono JS.

Int J Cancer. 2018 Jul 14. doi: 10.1002/ijc.31752. [Epub ahead of print]

PMID:
30006930
2.

All-printed cell counting chambers with on-chip sample preparation for point-of-care CD4 counting.

Wasserberg D, Zhang X, Breukers C, Connell BJ, Baeten E, van den Blink D, S O L À Benet È, Bloem AC, Nijhuis M, Wensing AMJ, Terstappen LWMM, Beck M.

Biosens Bioelectron. 2018 Jul 3;117:659-668. doi: 10.1016/j.bios.2018.07.002. [Epub ahead of print]

PMID:
30005387
3.

Evidence on the cost of breast cancer drugs is required for rational decision making.

Berghuis AMS, Koffijberg H, Terstappen LWMM, Sleijfer S, IJzerman MJ.

Ecancermedicalscience. 2018 Apr 16;12:825. doi: 10.3332/ecancer.2018.825. eCollection 2018.

4.

Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts.

Lorente D, Olmos D, Mateo J, Dolling D, Bianchini D, Seed G, Flohr P, Crespo M, Figueiredo I, Miranda S, Scher HI, Terstappen LWMM, de Bono JS.

Ann Oncol. 2018 Jul 1;29(7):1554-1560. doi: 10.1093/annonc/mdy172.

PMID:
29741566
5.

Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients.

Nanou A, Coumans FAW, van Dalum G, Zeune LL, Dolling D, Onstenk W, Crespo M, Fontes MS, Rescigno P, Fowler G, Flohr P, Brune C, Sleijfer S, de Bono JS, Terstappen LWMM.

Oncotarget. 2018 Apr 10;9(27):19283-19293. doi: 10.18632/oncotarget.25019. eCollection 2018 Apr 10.

6.

Parallel probing of drug uptake of single cancer cells on a microfluidic device.

Yang Y, Le Gac S, Terstappen LW, Rho HS.

Electrophoresis. 2018 Feb;39(3):548-556. doi: 10.1002/elps.201700351. Epub 2017 Dec 21.

PMID:
29193175
7.

Quantifying HER-2 expression on circulating tumor cells by ACCEPT.

Zeune L, van Dalum G, Decraene C, Proudhon C, Fehm T, Neubauer H, Rack B, Alunni-Fabbroni M, Terstappen LWMM, van Gils SA, Brune C.

PLoS One. 2017 Oct 30;12(10):e0186562. doi: 10.1371/journal.pone.0186562. eCollection 2017.

8.

Surface Plasmon Resonance is an Analytically Sensitive Method for Antigen Profiling of Extracellular Vesicles.

Gool EL, Stojanovic I, Schasfoort RBM, Sturk A, van Leeuwen TG, Nieuwland R, Terstappen LWMM, Coumans FAW.

Clin Chem. 2017 Oct;63(10):1633-1641. doi: 10.1373/clinchem.2016.271049. Epub 2017 Aug 7.

PMID:
28784692
9.

Isolation of single cells for protein therapeutics using microwell selection and Surface Plasmon Resonance imaging.

Abali F, Stevens M, Tibbe AGJ, Terstappen LWMM, van der Velde PN, Schasfoort RBM.

Anal Biochem. 2017 Aug 15;531:45-47. doi: 10.1016/j.ab.2017.05.021. Epub 2017 May 22.

10.

Distinguishing septic from normal donors by detection of sPLA2-IIA from human plasma using a microsieve-based immunoassay.

Zweitzig DR, Tibbe AG, Kopnitsky MJ, Cichonski K, Terstappen LWMM.

J Immunol Methods. 2017 Aug;447:86-91. doi: 10.1016/j.jim.2017.04.007. Epub 2017 Apr 19.

PMID:
28433579
11.

Detecting Blood-Based Biomarkers in Metastatic Breast Cancer: A Systematic Review of Their Current Status and Clinical Utility.

Berghuis AM, Koffijberg H, Prakash J, Terstappen LW, IJzerman MJ.

Int J Mol Sci. 2017 Feb 9;18(2). pii: E363. doi: 10.3390/ijms18020363. Review.

12.

DNA Detection by Flow Cytometry using PNA-Modified Metal-Organic Framework Particles.

Mejia-Ariza R, Rosselli J, Breukers C, Manicardi A, Terstappen LW, Corradini R, Huskens J.

Chemistry. 2017 Mar 23;23(17):4180-4186. doi: 10.1002/chem.201605803. Epub 2017 Feb 28.

13.

Improving the CellSearch® system.

Swennenhuis JF, van Dalum G, Zeune LL, Terstappen LW.

Expert Rev Mol Diagn. 2016 Dec;16(12):1291-1305. Epub 2016 Nov 17.

PMID:
27797592
14.

Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulating Tumor Cells in Small Cell Lung Cancer.

Pore M, Meijer C, de Bock GH, Boersma-van Ek W, Terstappen LW, Groen HJ, Timens W, Kruyt FA, Hiltermann TJ.

Clin Lung Cancer. 2016 Nov;17(6):535-542. doi: 10.1016/j.cllc.2016.05.015. Epub 2016 Jun 8.

PMID:
27363902
15.

Temperature-Switch Cytometry-Releasing Antibody on Demand from Inkjet-Printed Gelatin for On-Chip Immunostaining.

Zhang X, Wasserberg D, Breukers C, Terstappen LW, Beck M.

ACS Appl Mater Interfaces. 2016 Oct 11. [Epub ahead of print]

PMID:
27684590
16.

Feasibility of a simple microsieve-based immunoassay platform.

Zweitzig DR, Tibbe AG, Nguyen AT, van Rijn CJ, Kopnitsky MJ, Cichonski K, Terstappen LW.

J Immunol Methods. 2016 Oct;437:21-7. doi: 10.1016/j.jim.2016.07.002. Epub 2016 Jul 21.

PMID:
27448458
17.

Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer.

Lorente D, Olmos D, Mateo J, Bianchini D, Seed G, Fleisher M, Danila DC, Flohr P, Crespo M, Figueiredo I, Miranda S, Baeten K, Molina A, Kheoh T, McCormack R, Terstappen LW, Scher HI, de Bono JS.

Eur Urol. 2016 Dec;70(6):985-992. doi: 10.1016/j.eururo.2016.05.023. Epub 2016 Jun 9.

18.

Capture of Tumor Cells on Anti-EpCAM-Functionalized Poly(acrylic acid)-Coated Surfaces.

Andree KC, Barradas AM, Nguyen AT, Mentink A, Stojanovic I, Baggerman J, van Dalum J, van Rijn CJ, Terstappen LW.

ACS Appl Mater Interfaces. 2016 Jun 15;8(23):14349-56. doi: 10.1021/acsami.6b01241. Epub 2016 Jun 1.

PMID:
27187784
19.

Controlled antibody release from gelatin for on-chip sample preparation.

Zhang X, Wasserberg D, Breukers C, Terstappen LW, Beck M.

Analyst. 2016 May 10;141(10):3068-76. doi: 10.1039/c5an02090e.

PMID:
27077142
20.

Modeling single cell antibody excretion on a biosensor.

Stojanović I, Baumgartner W, van der Velden TJ, Terstappen LW, Schasfoort RB.

Anal Biochem. 2016 Jul 1;504:1-3. doi: 10.1016/j.ab.2016.03.018. Epub 2016 Mar 31.

PMID:
27040182
21.

Interpolation method for accurate affinity ranking of arrayed ligand-analyte interactions.

Schasfoort RB, Andree KC, van der Velde N, van der Kooi A, Stojanović I, Terstappen LW.

Anal Biochem. 2016 May 1;500:21-3. doi: 10.1016/j.ab.2016.01.023. Epub 2016 Feb 13.

PMID:
26878776
22.

Challenges in circulating tumor cell detection by the CellSearch system.

Andree KC, van Dalum G, Terstappen LW.

Mol Oncol. 2016 Mar;10(3):395-407. doi: 10.1016/j.molonc.2015.12.002. Epub 2015 Dec 25. Review.

23.

Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer.

Janni WJ, Rack B, Terstappen LW, Pierga JY, Taran FA, Fehm T, Hall C, de Groot MR, Bidard FC, Friedl TW, Fasching PA, Brucker SY, Pantel K, Lucci A.

Clin Cancer Res. 2016 May 15;22(10):2583-93. doi: 10.1158/1078-0432.CCR-15-1603. Epub 2016 Jan 5.

24.

Programmable v-type valve for cell and particle manipulation in microfluidic devices.

Rho HS, Yang Y, Hanke AT, Ottens M, Terstappen LW, Gardeniers H.

Lab Chip. 2016 Jan 21;16(2):305-11. doi: 10.1039/c5lc01206f.

PMID:
26648416
25.

Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution.

Stoecklein NH, Fischer JC, Niederacher D, Terstappen LW.

Expert Rev Mol Diagn. 2016;16(2):147-64. doi: 10.1586/14737159.2016.1123095. Epub 2015 Dec 16. Review.

PMID:
26587751
26.

CCR 20th Anniversary Commentary: Circulating Tumor Cells in Prostate Cancer.

Mehra N, Zafeiriou Z, Lorente D, Terstappen LW, de Bono JS.

Clin Cancer Res. 2015 Nov 15;21(22):4992-5. doi: 10.1158/1078-0432.CCR-14-3129.

27.

Microfluidic device for DNA amplification of single cancer cells isolated from whole blood by self-seeding microwells.

Yang Y, Rho HS, Stevens M, Tibbe AG, Gardeniers H, Terstappen LW.

Lab Chip. 2015 Nov 21;15(22):4331-7. doi: 10.1039/c5lc00816f.

PMID:
26400672
28.

The detection of EpCAM(+) and EpCAM(-) circulating tumor cells.

de Wit S, van Dalum G, Lenferink AT, Tibbe AG, Hiltermann TJ, Groen HJ, van Rijn CJ, Terstappen LW.

Sci Rep. 2015 Jul 17;5:12270. doi: 10.1038/srep12270.

29.

CCR 20th Anniversary Commentary: Paving the Way for Circulating Tumor Cells.

Allard WJ, Terstappen LW.

Clin Cancer Res. 2015 Jul 1;21(13):2883-5. doi: 10.1158/1078-0432.CCR-14-2559.

30.

Quantification of antibody production of individual hybridoma cells by surface plasmon resonance imaging.

Stojanović I, van der Velden TJ, Mulder HW, Schasfoort RB, Terstappen LW.

Anal Biochem. 2015 Sep 15;485:112-8. doi: 10.1016/j.ab.2015.06.018. Epub 2015 Jun 18.

PMID:
26095397
31.

Self-seeding microwell chip for the isolation and characterization of single cells.

Swennenhuis JF, Tibbe AG, Stevens M, Katika MR, van Dalum J, Tong HD, van Rijn CJ, Terstappen LW.

Lab Chip. 2015 Jul 21;15(14):3039-46. doi: 10.1039/c5lc00304k.

PMID:
26082273
32.

Androgen receptor expression in circulating tumour cells from castration-resistant prostate cancer patients treated with novel endocrine agents.

Crespo M, van Dalum G, Ferraldeschi R, Zafeiriou Z, Sideris S, Lorente D, Bianchini D, Rodrigues DN, Riisnaes R, Miranda S, Figueiredo I, Flohr P, Nowakowska K, de Bono JS, Terstappen LW, Attard G.

Br J Cancer. 2015 Mar 31;112(7):1166-74. doi: 10.1038/bjc.2015.63.

33.

Importance of circulating tumor cells in newly diagnosed colorectal cancer.

van Dalum G, Stam GJ, Scholten LF, Mastboom WJ, Vermes I, Tibbe AG, De Groot MR, Terstappen LW.

Int J Oncol. 2015 Mar;46(3):1361-8. doi: 10.3892/ijo.2015.2824. Epub 2015 Jan 9.

PMID:
25572133
34.

Label-free imaging and identification of typical cells of acute myeloid leukaemia and myelodysplastic syndrome by Raman microspectroscopy.

Vanna R, Ronchi P, Lenferink AT, Tresoldi C, Morasso C, Mehn D, Bedoni M, Picciolini S, Terstappen LW, Ciceri F, Otto C, Gramatica F.

Analyst. 2015 Feb 21;140(4):1054-64. doi: 10.1039/c4an02127d.

PMID:
25568900
35.

Circulating tumor cells before and during follow-up after breast cancer surgery.

van Dalum G, van der Stam GJ, Tibbe AG, Franken B, Mastboom WJ, Vermes I, de Groot MR, Terstappen LW.

Int J Oncol. 2015 Jan;46(1):407-13. doi: 10.3892/ijo.2014.2694. Epub 2014 Oct 6.

PMID:
25339612
36.

Parallel single cancer cell whole genome amplification using button-valve assisted mixing in nanoliter chambers.

Yang Y, Swennenhuis JF, Rho HS, Le Gac S, Terstappen LW.

PLoS One. 2014 Sep 18;9(9):e107958. doi: 10.1371/journal.pone.0107958. eCollection 2014.

37.

Detection of circulating tumor cells.

de Wit S, van Dalum G, Terstappen LW.

Scientifica (Cairo). 2014;2014:819362. doi: 10.1155/2014/819362. Epub 2014 Jul 15. Review.

38.

Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis.

Barradas AM, Terstappen LW.

Cancers (Basel). 2013 Dec 4;5(4):1619-42. doi: 10.3390/cancers5041619.

39.

Efficiency of whole genome amplification of single circulating tumor cells enriched by CellSearch and sorted by FACS.

Swennenhuis JF, Reumers J, Thys K, Aerssens J, Terstappen LW.

Genome Med. 2013 Nov 29;5(11):106. doi: 10.1186/gm510. eCollection 2013.

40.

Analysis of cell surface antigens by Surface Plasmon Resonance imaging.

Stojanović I, Schasfoort RB, Terstappen LW.

Biosens Bioelectron. 2014 Feb 15;52:36-43. doi: 10.1016/j.bios.2013.08.027. Epub 2013 Aug 27.

PMID:
24016537
41.

Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer.

Ligthart ST, Coumans FA, Bidard FC, Simkens LH, Punt CJ, de Groot MR, Attard G, de Bono JS, Pierga JY, Terstappen LW.

PLoS One. 2013 Jun 27;8(6):e67148. doi: 10.1371/journal.pone.0067148. Print 2013.

42.

Detection of cancer before distant metastasis.

Coumans FA, Siesling S, Terstappen LW.

BMC Cancer. 2013 Jun 13;13:283. doi: 10.1186/1471-2407-13-283.

43.

Filtration parameters influencing circulating tumor cell enrichment from whole blood.

Coumans FA, van Dalum G, Beck M, Terstappen LW.

PLoS One. 2013 Apr 26;8(4):e61774. doi: 10.1371/journal.pone.0061774. Print 2013.

44.

Filter characteristics influencing circulating tumor cell enrichment from whole blood.

Coumans FA, van Dalum G, Beck M, Terstappen LW.

PLoS One. 2013 Apr 23;8(4):e61770. doi: 10.1371/journal.pone.0061770. Print 2013.

45.

Label-free cell profiling.

Schasfoort RB, Bentlage AE, Stojanovic I, van der Kooi A, van der Schoot E, Terstappen LW, Vidarsson G.

Anal Biochem. 2013 Aug 1;439(1):4-6. doi: 10.1016/j.ab.2013.04.001. Epub 2013 Apr 11.

PMID:
23583822
46.

Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancer.

Smerage JB, Budd GT, Doyle GV, Brown M, Paoletti C, Muniz M, Miller MC, Repollet MI, Chianese DA, Connelly MC, Terstappen LW, Hayes DF.

Mol Oncol. 2013 Jun;7(3):680-92. doi: 10.1016/j.molonc.2013.02.013. Epub 2013 Mar 14.

47.

Interpretation of changes in circulating tumor cell counts.

Coumans FA, Ligthart ST, Terstappen LW.

Transl Oncol. 2012 Dec;5(6):486-91. Epub 2012 Dec 1.

48.

Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer.

Ligthart ST, Bidard FC, Decraene C, Bachelot T, Delaloge S, Brain E, Campone M, Viens P, Pierga JY, Terstappen LW.

Ann Oncol. 2013 May;24(5):1231-8. doi: 10.1093/annonc/mds625. Epub 2012 Dec 27.

PMID:
23275633
49.

Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer.

Franken B, de Groot MR, Mastboom WJ, Vermes I, van der Palen J, Tibbe AG, Terstappen LW.

Breast Cancer Res. 2012 Oct 22;14(5):R133. doi: 10.1186/bcr3333.

50.

Metastasis and Circulating Tumor Cells.

van Dalum G, Holland L, Terstappen LW.

EJIFCC. 2012 Oct 12;23(3):87-97. eCollection 2012 Oct.

Supplemental Content

Loading ...
Support Center